Yuanbin Ru

2.2k total citations · 1 hit paper
17 papers, 1.3k citations indexed

About

Yuanbin Ru is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yuanbin Ru has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Yuanbin Ru's work include RNA Research and Splicing (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Glycogen Storage Diseases and Myoclonus (2 papers). Yuanbin Ru is often cited by papers focused on RNA Research and Splicing (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Glycogen Storage Diseases and Myoclonus (2 papers). Yuanbin Ru collaborates with scholars based in United States, Australia and Italy. Yuanbin Ru's co-authors include Dan Theodorescu, Paula Hoffman, Richard A. Radcliffe, Spencer Mahaffey, George A. Călin, Simona Rossi, Boris Tabakoff, Russell P. Bowler, Lynne Bemis and Katerina Kechris and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and JNCI Journal of the National Cancer Institute.

In The Last Decade

Yuanbin Ru

17 papers receiving 1.3k citations

Hit Papers

The multiMiR R package and database: integration of micro... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanbin Ru United States 15 846 524 357 182 175 17 1.3k
Françoise Descôtes France 20 593 0.7× 326 0.6× 342 1.0× 247 1.4× 154 0.9× 66 1.2k
Jun Hou China 17 673 0.8× 235 0.4× 288 0.8× 203 1.1× 245 1.4× 62 1.1k
Katsuhiro Anami Japan 18 706 0.8× 389 0.7× 372 1.0× 153 0.8× 283 1.6× 35 1.2k
Gian Paolo Tonini Italy 25 947 1.1× 523 1.0× 337 0.9× 170 0.9× 119 0.7× 88 1.8k
Vasyl Vasko United States 21 659 0.8× 293 0.6× 602 1.7× 190 1.0× 169 1.0× 38 1.7k
Cuiqi Zhou United States 21 687 0.8× 297 0.6× 279 0.8× 225 1.2× 75 0.4× 35 1.3k
Bin Chang China 21 717 0.8× 308 0.6× 440 1.2× 135 0.7× 225 1.3× 52 1.3k
Elise Nilsson Sweden 15 657 0.8× 290 0.6× 213 0.6× 112 0.6× 192 1.1× 19 988
Ian A.J. Lorimer Canada 21 710 0.8× 399 0.8× 518 1.5× 129 0.7× 308 1.8× 41 1.3k

Countries citing papers authored by Yuanbin Ru

Since Specialization
Citations

This map shows the geographic impact of Yuanbin Ru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanbin Ru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanbin Ru more than expected).

Fields of papers citing papers by Yuanbin Ru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanbin Ru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanbin Ru. The network helps show where Yuanbin Ru may publish in the future.

Co-authorship network of co-authors of Yuanbin Ru

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanbin Ru. A scholar is included among the top collaborators of Yuanbin Ru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanbin Ru. Yuanbin Ru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Estrada, Karol, Steven Froelich, Arthur Wüster, et al.. (2021). Identifying therapeutic drug targets using bidirectional effect genes. Nature Communications. 12(1). 2224–2224. 18 indexed citations
2.
Ru, Yuanbin, Andrew C. Melton, Adam Harris, et al.. (2019). Neurofilament light is a treatment‐responsive biomarker in CLN2 disease. Annals of Clinical and Translational Neurology. 6(12). 2437–2447. 19 indexed citations
3.
Huo, Dezheng, Hai Hu, Suhn K. Rhie, et al.. (2017). Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas. JAMA Oncology. 3(12). 1654–1654. 184 indexed citations
4.
Ru, Yuanbin, Jianfang Liu, J. Leigh Fantacone-Campbell, et al.. (2017). Comparative Survival Analysis of Invasive Breast Cancer Patients Treated by a U.S. Military Medical Center and Matched Patients From the U.S. General Population. Military Medicine. 182(11). e1851–e1858. 8 indexed citations
5.
Ru, Yuanbin, et al.. (2016). CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL). BMC Cancer. 16(1). 713–713. 25 indexed citations
6.
Murai, Junko, Ying Feng, Guoying Karen Yu, et al.. (2016). Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition. Oncotarget. 7(47). 76534–76550. 219 indexed citations
7.
Guin, Sunny, Yuanbin Ru, Neeraj Agarwal, et al.. (2015). Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis. Clinical Cancer Research. 22(5). 1274–1283. 24 indexed citations
8.
Sun, Xiaoyong, et al.. (2015). SplicingTypesAnno: Annotating and quantifying alternative splicing events for RNA-Seq data. Computer Methods and Programs in Biomedicine. 119(1). 53–62. 9 indexed citations
9.
Guin, Sunny, Courtney Pollard, Yuanbin Ru, et al.. (2014). Role in Tumor Growth of a Glycogen Debranching Enzyme Lost in Glycogen Storage Disease. JNCI Journal of the National Cancer Institute. 106(5). 36 indexed citations
10.
Ru, Yuanbin, Katerina Kechris, Boris Tabakoff, et al.. (2014). The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations. Nucleic Acids Research. 42(17). e133–e133. 475 indexed citations breakdown →
11.
Wang, Hong, Yuanbin Ru, Marta Sänchez‐Carbayo, et al.. (2013). Translation Initiation Factor eIF3b Expression in Human Cancer and Its Role in Tumor Growth and Lung Colonization. Clinical Cancer Research. 19(11). 2850–2860. 68 indexed citations
12.
Guin, Sunny, Yuanbin Ru, Murry W. Wynes, et al.. (2013). Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression. Journal of Thoracic Oncology. 8(12). 1492–1501. 39 indexed citations
13.
Dancik, Garrett M., Yuanbin Ru, Charles R. Owens, & Dan Theodorescu. (2011). A Framework to Select Clinically Relevant Cancer Cell Lines for Investigation by Establishing Their Molecular Similarity with Primary Human Cancers. Cancer Research. 71(24). 7398–7409. 21 indexed citations
14.
Ru, Yuanbin, Garrett M. Dancik, & Dan Theodorescu. (2011). Biomarkers for prognosis and treatment selection in advanced bladder cancer patients. Current Opinion in Urology. 21(5). 420–427. 35 indexed citations
15.
Smith, Steven C., Alexander S. Baras, Garrett M. Dancik, et al.. (2011). A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment. The Lancet Oncology. 12(2). 137–143. 100 indexed citations
16.
Wilkerson, Matthew D., Yuanbin Ru, & Volker Brendel. (2009). Common introns within orthologous genes: software and application to plants. Briefings in Bioinformatics. 10(6). 631–644. 26 indexed citations
17.
Ru, Yuanbin, et al.. (2008). Spliceosomal Proteins in Plants. Current topics in microbiology and immunology. 326. 1–15. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026